Glaukos Corp (GKOS)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$87.72

Buy

$126.13

arrow-down$-0.35 (-0.32%)

Prices updated at 12 Dec 2025, 22:59 EST

Prices minimum 15 mins delay

Prices in USD

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	315m	383m
	239m	289m
	-124m	-108m
	-39.31	-28.20
	-135m	-146m
	-82m	-96m
Sales, General and administrative	224m	261m
Interest expenses	14m	10m
Provision for income taxes	934,000	771,000
Operating expenses	363m	398m
Income before taxes	-134m	-146m
Net income available to common shareholders	-135m	-146m
	-2.78	-2.77
Net interest income	-4m	1m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-2.78	-2.77
Free cash flow per share	-1.5678	-1.5913
Book value/share	9.7243	11.8438
Debt equity ratio	0.831023	0.134822

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	395m	450m
Current liabilities	74m	75m
Total capital	745m	767m
Total debt	384m	103m
Total equity	462m	767m
Total non current liabilities	-	-
Loans	283m	-
Total assets	940m	975m
Total liabilities	-	-
Cash and cash equivalents	93m	170m
Common stock	49m	56m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	127m	99m
Cash dividends paid	-	-
	-78m	-68m
Investments (gains) losses	14m	48m
	99m	174m
Net income	-	-
	-58m	-61m
	-20m	-6m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.